NEW YORK, March 6, 2021 / PRNewswire / – WHY: Rosen Law Firm, a global investment rights law firm, announces that a class action lawsuit will be filed on behalf of customers of Athenex, Inc. securities. (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021, inclusive (the “class time”). A class action lawsuit has already been filed. If you want to be the main complaint, you have to move the Court not to exceed May 3, 2021.
SO WHAT: If you purchased Athenex securities during Class Time you may be entitled to compensation without incurring any costs or expenses through a contingent tax arrangement.
WHAT TO DO: To join an Athenex class action, go to http://www.rosenlegal.com/cases-register-2051.html or phone Phillip Kim, Esq. no fees at 866-767-3653 or email [email protected] no [email protected] for information about the class activity. A class action lawsuit has already been filed. If you want to be the main complaint, you have to move the Court not to exceed May 3, 2021. A chief planner is a representative party acting on behalf of other class members in administering the law.
WHY: We encourage investors to choose certified advice with a history of success in management positions. Issuing companies often do not have comparable knowledge or resources. Rosen Law Firm represents investors around the globe, focusing their use in securities class actions and legalizing shareholder sub-shares. Rosen Law Firm has executed the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was ranked at No. 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017. The firm has been ranked in the top 3 annually since 2013 and has get back hundreds of millions of dollars to investors. In 2019 alone the company took over $ 438 million for investors. In 2020 founding partner Laurence Rosen named by the law360 as the Titan Bar of Plaintiffs. Many of the firm’s lawyers are recognized by Lawdragon and Super Lawyers.
CASE INFORMATION: According to the lawsuit, defendants during the Class Period made false and / or misleading statements and / or failed: (1) that the data included in the Oral New Drug Request Paclitaxel and Encequidar (“NDA”) pose a safety risk to patients against an increase in sequalae associated with neutropenia; (2) the uncertainty regarding the main endpoint results of the target response rate (“ORR”) at week 19 produced by a blinded independent median review (“BICR”); (3) the BICR clearance and revision process may have introduced bias and disproportionate impact on BICR; (4) the Company’s Level 3 study used to include the NDA was inappropriate and poorly conducted in a population of patients with metastatic breast cancer representing the U.S. population, until the FDA would recommend such a new clinical trial; (5) as a result, it was expected that the FDA would not approve the Company’s NDA in its current form; and (6) as a result, the Company’s public statements were misleading and misleading at all material times. Once the real details entered the market, the lawsuit alleges that investors suffered damage.
To join an Athenex class action, go to http://www.rosenlegal.com/cases-register-2051.html or phone Phillip Kim, Esq. no fees at 866-767-3653 or email [email protected] no [email protected] for information about the class activity.
No classes were confirmed. Until a class is confirmed, you will not be represented by an adviser unless you book one. You can choose a consultant of your choice. You can also remain an absent class member and do nothing at this stage. An investor’s ability to share in any future improvement is not dependent on serving as a key complaint.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Lawyer advertising. Previous results do not guarantee a similar result.
Contact information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Law Firm Rosen, PA
275 Madison Avenue, 40th floor
New York, NY 10016
Phone: (212) 686-1060
Hole free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com
SOURCE Rosen Law Firm, PA
Related Links
www.rosenlegal.com